Fast-acting anti-rabies drug set for India launch


The first fast-acting anti-rabies drug of the world, which instantly deactivates the rabies virus and provides immediate protection in severe dog bite cases, is set for a launch in India this year.The drug, rabies human monoclonal antibody (RMAb), has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical School. It has been found safe and effective during various phases of human clinical trials spanning nine years in India and abroad.